Clinical trials
Terminated Anemia, Refractory trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Wake Forest University Health Sciences | 2 |
| Alison Walker | 1 |
| CTI BioPharma | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| OHSU Knight Cancer Institute | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Medicine and Dentistry of New Jersey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory | 14 |
| Anemia, Refractory, with Excess of Blasts | 14 |
| Myelodysplastic Syndromes | 14 |
| Leukemia | 12 |
| Leukemia, Myelomonocytic, Chronic | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Leukemia, Myeloid, Acute | 7 |
| Myeloproliferative Disorders | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma | 6 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.